We assessed the MAP1B-LC1 levels in the post mortem samples, and we observed an increase of this protein in the synaptosome fraction of FUS-ALS patients compared to controls (Figures 3K and 3L). This evidence concerns the gene MAP1B and amyotrophic lateral sclerosis.